GRCL
Get informed when a big investor buys or sells
+ Follow| Market cap | $197.97 Million |
|---|---|
| Enterprise Value | $-1,363,595,580.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-44.85 |
| Beta | -0.35 |
| Outstanding Shares | 16,784,936 |
| P/E Ratio | -1.54 |
|---|---|
| PEG | 2.54 |
| Price to Sales | - |
| Price to Book Ratio | 0.11 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.36 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.07 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Gracell Biotechnologies Inc. (